Chargement en cours...

Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma

With the advent of new targeted drugs in hematology and oncology patient prognosis is improved. Combination with antifungal prophylaxis challenges clinicians due to pharmacological profiles prone to drug–drug interactions (DDI). Midostaurin is a novel agent for FLT3-TKD/-ITD(mut)-acute myeloid leuke...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Hematol
Auteurs principaux: Stemler, Jannik, Koehler, Philipp, Maurer, Christian, Müller, Carsten, Cornely, Oliver A.
Format: Artigo
Langue:Inglês
Publié: Springer Berlin Heidelberg 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7316674/
https://ncbi.nlm.nih.gov/pubmed/32514626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-04107-1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!